1Kadyrov M,Kingdom JC,Huppertz B.Divergent tropho-blast Invasion and apoptosis in placental bed spiral arter-ies from pregnancies complicated by maternal anemia andearly-onset preeclampsia/intrauterine growth restriction[J].Am J Obstet Gynecol,2006,194(2):557-563.
2Caniggia I,Winter JL.Hypoxia inducible factor-1:oxygenregulation of trophoblast differentiation in normal and pre-eclamptic pregnancies-a review[J].Placenta,2002,23:47-57.
3Chedraui P,Lockwood CJ,Schatz F,et al.Increased plas-ma soluble fms-like tyrosine kinase 1 and endoglin levelsin pregnancies complicated with preeclampsia[J].MaternFetal Neonatal Med,2009,6(4):1-6.
4Lukanov TH,Bqjmova SI,Popova VS,et al.Flow cytomet-ric investigation of CD40-CD40 ligand system in pre-eclampsia and normal pregnancyI[J].Clin Appl ThrombHemost,2009,2(4):12-15.
6Nishizawa H,Pryor-Koishi K,Kato T,et al.Microarray a-nalysis of differentially expressed fetal genes in placentaltissue derived from early and late onset severe pre-eclamp-sia[J].Placenta,2007,28(5-6):487-497.
7Withage MI,Wallenburg HC,Steegers EA,et al.Morbidityand development in childhood of infants born after tempo-rising treatment of early onset preeclampsia[J].BJOG,2005,1-12(7):910-914.
9Haddad B,Deis S,Goffinet F,et al.Maternal and perinataloutcomes during expectant management of 239 severe pre-eclampsia women between 24 and 33 weeks'gestation[J].AJOG,2004,190(6):1590-1597.
3Bolte AC, van Geijn HP, Dekker GA. Management and monitoring of severe preeelampsia [ J ]. Eur J Obstet Gynecol Reprod Bio1,2001,96( 1 ) :8-20.
4Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term : patient selection, treatment, and delivery indications [ J ]. Am J Obstet Gynecol, 2007,196 ( 6 ) : 514e1-9.
5Haddad B, Kayem G, Deis S, et al. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growtfi restriction? [ J]. Am J Obstet Gyneco1,2007,196 ( 3 ) :237el-5.
6Hall DR, Grov D, Carstens E. Early pre-eelampsia: what proportion of women qualify for expectant management and if not, why not? [ J]. Eur J Obstet Gynecol Reprod Biol,2006, 128( 1- 2) : 169-174.
7Bloomenthal D, yon Dadelszen P, Liston R. The effect of factor V Leiden carriage on maternal and fetal health [ J ]. CMAJ, 2002,167( 1 ) :48-54.
8Steyn DW, Odendaal H J, Hall DR. Diurinal blood pressure variation in the evaluation of early onset severe pre-eclampsia [ J ]. Eur J Obstet Gynecol Reprod Biol,2008,138 (2) :141-146.
9Price CP, Newall RG, Boyd JC. Use of protein : creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review[ J]. Clin Chem, 2005,51 (9) :1577-1586.
10Keiler H, Zettergren T, Svensson H, et al. Assessing urinary albumin excretion in pre-eclamptic women : which sample to use? [J]. BJOG,2003 ,110 :12-17.
